Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
118.36B
Market cap118.36B
Price-Earnings ratio
17.16
Price-Earnings ratio17.16
Dividend yield
4.19%
Dividend yield4.19%
Average volume
11.07M
Average volume11.07M
High today
$59.63
High today$59.63
Low today
$58.09
Low today$58.09
Open price
$59.16
Open price$59.16
Volume
12.85M
Volume12.85M
52 Week high
$62.89
52 Week high$62.89
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

The current Bristol-Myers Squibb(BMY) stock price is $58.23, with a market capitalization of 118.36B. The stock trades at a price-to-earnings (P/E) ratio of 17.16 and offers a dividend yield of 4.2%.

During the trading session on 2026-03-19, Bristol-Myers Squibb(BMY) shares reached a daily high of $59.63 and a low of $58.09. At a current price of $58.23, the stock is +0.2% higher than the low and still -2.3% under the high.

Trading volume for Bristol-Myers Squibb(BMY) stock has reached 12.85M, versus its average volume of 11.07M.

Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $62.89 and a low of $42.52.

Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $62.89 and a low of $42.52.

BMY News

TipRanks 2d
Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb Co. (BMY) is running a Phase 1 study called “A Stu...

Simply Wall St 2d
Opdualag’s NHS Scotland Debut Adds New Layer To Bristol-Myers Squibb Story

Bristol-Myers Squibb's Opdualag has been introduced as a first-line immunotherapy option for advanced melanoma in NHS Scotland. The treatment combines nivoluma...

Opdualag’s NHS Scotland Debut Adds New Layer To Bristol-Myers Squibb Story
TipRanks 6d
BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb (BMY) is running a real-world chart review study c...

Analyst ratings

58%

of 31 ratings
Buy
38.7%
Hold
58.1%
Sell
3.2%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.